Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco.

[1] Founded in 2007, the firm invests in biotechnology startups.

[2] Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.

This United States corporation or company article is a stub.

You can help Wikipedia by expanding it.